Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal FibroblastsYohei Asano, Robert M. Hoffman, HIROAKI KIMURA et al.|Anticancer Research|2025Cited by 2
Osteosarcoma patient-derived orthotopic xenograft (PDOX) models for identification of novel and effective therapeutics.Takashi Higuchi, Kentaro Igarashi, Robert M. Hoffman et al.|Journal of Clinical Oncology|2024Cited by 1
Eradication of Extensive Lymph‐Node, Bone and Pleural Metastases of a Breast‐Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant MethioninaseYohei Asano, Robert M. Hoffman, TOSHIHIKO SATO et al.|Cancer Diagnosis & Prognosis|2025Cited by 1
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expressionSei Morinaga, Robert M. Hoffman, Qinghong Han et al.|Frontiers in Oncology|2025Cited by 1